CSIMarket Company Name, Ticker, Suppliers, else..
 
Lifecore Biomedical Inc   (NASDAQ: LFCR)
 
Price: $4.4000 $0.05 1.149%
Day's High: $4.599999904632568 Week Perf: -1.35 %
Day's Low: $ 4.29 30 Day Perf: -9.09 %
Volume (M): 277,093 52 Wk High: $ 8.98
Volume (M$): $ 0 52 Wk Avg: $6.18
Open: $4.35 52 Wk Low: $3.63



 Market Capitalization (Millions $) 165
 Shares Outstanding (Millions) 37
 Employees 209
 Revenues (TTM) (Millions $) 125
 Net Income (TTM) (Millions $) -46
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 10

Business Description


Lifecore Biomedical, Inc. is a contract development and manufacturing organization (CDMO) specializing in the development, cGMP manufacturing, and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drugs and medical device products. The company manufactures pharmaceutical-grade, non-animal-sourced hyaluronic acid (HA) and provides vertically integrated services from raw material supply to finished sterile injectable products. Lifecore serves medical applications including ophthalmic and orthopedic uses. The company operates multiple cGMP facilities, holds various regulatory certifications, and is focused on expanding its manufacturing capacity and business development within the CDMO market.


   Company Address: 3515 Lyman Boulevard Chaska, 55318 MN
   Company Phone Number: 368-4300   Stock Exchange / Ticker: NASDAQ LFCR


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ARDX   -0.79%    
AYTU   -1.78%    
BHC        3.8% 
EOLS        4.73% 
ETON   -2.22%    
IRD        26.56% 
• View Complete Report
   



Partnership

Lifecore Biomedical Inc., a prominent player in the biotechnology sector, recently made ...

Published Wed, Oct 29 2025 2:31 PM UTC

Lifecore Biomedical: Navigating Challenges and Opportunities in the Injectable Pharmaceutical Market Lifecore Biomedical Inc., a prominent player in the biotechnology sector, recently made strides in securing its position within the competitive injectable pharmaceutical landscape by partnering with a leading global pharmaceutical company. This collaboration aims to execute ...
Contract

Lifecore Biomedical Partners with Nirsum Labs to Advance Novel Treatment for Opioid Use Disorder,

Published Thu, Dec 19 2024 12:01 PM UTC

Lifecore Biomedical and Nirsum Labs Collaborate on Development of Innovative Opioid Use Disorder Treatment Lifecore Biomedical, a renowned contract development and manufacturing organization (CDMO), has recently been selected by Nirsum Labs to provide comprehensive development and manufacturing services for NRS-033, a novel treatment aimed at addressing opioid use disorder. ...
Management Changes

Lifecore Biomedical Strengthens Operations and Financial Health with Key Appointment and $24.3 Million Capital Raise,

Published Mon, Nov 4 2024 12:00 PM UTC

Lifecore Biomedical Enhances Its Operational Foundation with Strategic Leadership Appointment and Capital InfusionIn a series of strategic maneuvers aimed at bolstering its operational capabilities and financial standing, Lifecore Biomedical Inc. has taken significant steps to navigate a challenging landscape within the life sciences sector. Recently, the company appointed ...
Financing Agreement

Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock

Published Fri, Oct 4 2024 11:20 AM UTC

Lifecore Biomedical Navigates Financial Challenges with Strategic PIPE Investment Despite Recent LossesIn a bold move to bolster its balance sheet and reinforce operational capabilities, Lifecore Biomedical Inc. announced a successful Private Investment in Public Equity (PIPE) transaction, raising $24.3 million. This infusion of capital comes at a critical juncture for the ...
Announcement

Investor Class Actions Filed Against Multiple Pharmaceutical and Tech Entities Key Deadlines and Implications for Sto...

Published Thu, Sep 19 2024 1:00 AM UTC

for CSIMarket.com In recent months, numerous class action lawsuits have been initiated against various companies, including Lifecore Biomedical, Inc. (NASDAQ: LFCR), Spire Global, Inc. (NYSE: SPIR), DexCom, Inc. (NASDAQ: DXCM), Arbor Realty Trust, Inc. (NYSE: ABR), and Oddity Tech (NASDAQ: ODD). These actions, led by notable investor rights law firms such as Bragar Eagel...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 1.32
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 1.01
Working Capital Ratio 3.79
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.09 $
Revenues (TTM) 3.34 $
Cash Flow (TTM) 0.02 $
Cash 0.55 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 598,469
Net Income per Employee (TTM) -220,029
Receivable Turnover Ratio (TTM) 9.14
Inventory Turnover Ratio (TTM) 2.76
Asset Turnover Ratio (TTM) 0.53

Profitability Ratios Current
Gross Margin (MRQ) 19.86 %
Operating Margin (MRQ) -20.8 %
Net Margin (MRQ) -70.73 %
Net Cash Flow Margin (MRQ) 14.81 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Lifecore Biomedical Inc's Segments
Reportable Segment    103.25 % of total Revenue
Revenues recognized over time    18.8 % of total Revenue
Revenues recognized at a point in time    84.45 % of total Revenue
CDMO    70.23 % of total Revenue
HA manufacturing    33.02 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.